DNAVSECC• 28 Days (Normalized)
DNA vs ECC (Ginkgo Bioworks Holdings Inc. vs Eagle Point Credit Company Common Share of Beneficial Interest)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $13
+92.59%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
ECC Performance $3.09
-16.49%
Eagle Point Credit Company Common Share of Beneficial Interest
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+109.08 pts
DNA outperforming by 109.08 percentage points
DNAECC
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA ECC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | DNA Price | DNA Gain (%) | ECC Price | ECC Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $13.00 | +92.59% | $3.09 | -16.49% | +109.08% |
| Oct 08, 2026 | $11.34 | +68.00% | $3.10 | -16.22% | +84.22% |
| Oct 07, 2026 | $11.47 | +69.93% | $3.09 | -16.49% | +86.42% |
| Oct 06, 2026 | $12.41 | +83.85% | $3.29 | -11.08% | +94.93% |
| Oct 05, 2026 | $14.98 | +121.93% | $3.41 | -7.84% | +129.77% |
| Oct 02, 2026 | $12.35 | +82.96% | $3.46 | -6.49% | +89.45% |
| Oct 01, 2026 | $12.50 | +85.19% | $- | - | |
| Sep 30, 2026 | $12.83 | +90.07% | $- | - | |
| Sep 29, 2026 | $11.96 | +77.19% | $3.49 | -5.81% | +83.00% |
| Sep 28, 2026 | $10.46 | +54.96% | $3.46 | -6.49% | +61.45% |
| Sep 25, 2026 | $10.66 | +57.93% | $3.50 | -5.41% | +63.34% |
| Sep 24, 2026 | $10.25 | +51.85% | $3.52 | -4.86% | +56.71% |
| Sep 23, 2026 | $8.58 | +27.11% | $3.57 | -3.51% | +30.62% |
| Sep 22, 2026 | $9.37 | +38.81% | $- | - | |
| Sep 21, 2026 | $7.98 | +18.22% | $3.60 | -2.70% | +20.92% |
Page 1 of 2